Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Biomedicines|March 28, 2024
100 Years since the Discovery of Insulin, from Its Discovery to the Insulins of the FutureCarmen Lambert, Elias Delgado
Cells|October 7, 2020
Cardiovascular Risk Factors and Differential Transcriptomic Profile of the Subcutaneous and Visceral Adipose Tissue and Their Resident Stem CellsGemma Arderiu, Carmen Lambert, Carlos Ballesta, et al.
Diabetology & Metabolic Syndrome|May 3, 2023
Reclassification of type 2 diabetes to type 1 diabetes in Asturias (Spain) between 2011 and 2020Raúl Rodríguez Escobedo, Carmen Lambert, Paula Morales Sánchez, et al.
International Journal of Molecular Sciences|January 8, 2023
Type 2 Diabetes in Obesity: A Systems Biology Study on Serum and Adipose Tissue Proteomic ProfilesGemma Arderiu, Guiomar Mendieta, Alex Gallinat, et al.
Stem Cell Research & Therapy|December 1, 2019
Stem cells from human cardiac adipose tissue depots show different gene expression and functional capacitiesCarmen Lambert, Gemma Arderiu, Maria Teresa Bejar, et al.
Nutrients|June 14, 2017
Phytosterols and Omega 3 Supplementation Exert Novel Regulatory Effects on Metabolic and Inflammatory Pathways: A Proteomic StudyCarmen Lambert, Judit Cubedo, Teresa Padró, et al.
Journal of Diabetes and Its Complications|November 8, 2024
Real-life evaluation of consensus recommendations for transition to subcutaneous insulin in hyperosmolar hyperglycemic crisesTomás González-Vidal, Diego Rivas-Otero, Jessica Ares-Blanco, et al.
Endocrinologia, Diabetes Y Nutricion|June 13, 2025
Predictors of length of hospital stay in patients presenting to the emergency department with hyperosmolar hyperglycemic crisesTomás González-Vidal, Diego Rivas-Otero, Carmen Lambert, et al.
Nutrients|March 3, 2018
Effects of a Carob-Pod-Derived Sweetener on Glucose MetabolismCarmen Lambert, Judit Cubedo, Teresa Padró, et al.
Revista Espanola De Salud Publica|November 3, 2023
[Cetoacidosis diabética al diagnóstico de diabetes mellitus tipo 1 en Asturias entre 2011 y 2020: influencia de la duración de los síntomas en la prevalencia de cetoacidosis y en la pérdida de peso.]Raúl Rodríguez Escobedo, Carmen Lambert, Belén Huidobro Fernández, et al.
Pageof 4